District Of Columbia Federal Judge Grants Injunction To Halt Orphan Drug Rule

Mealey's (June 12, 2015, 9:01 AM EDT) -- WASHINGTON, D.C. — A District of Columbia federal judge on May 23,2014, granted a pharmaceutical manufacturer’s motions for an injunction and summary judgment in a case challenging a final rule of the U.S. Department of Health and Human Service (HHS) related to when an orphan drug may be offered at a discounted price, saying that HHS lacked the authority to engage in the rulemaking process in this instance (Pharmaceutical Research and Manufacturers of America v. U.S. Department of Health and Human Service, No. 13-1501, D. D.C.;...
To view the full article, register now.